WHX Dubai 2026 Rapid Brief

Michikazu Koshiba, Director of Healthcare & Well-being, Advisory Services at KPMG in Japan, recently attended World Health Expo (WHX) Dubai 2026, formerly known as Arab Health, one of the world’s largest and most influential global healthcare and life sciences gatherings, held in Dubai in February 2026. This rapid brief summarizes key insights and observations from WHX, with a particular focus on the depth and diversity of its agenda, including life‑course‑oriented Women’s Health, Middle East–Africa (MEA) market strategies, and the evolving regulatory and manufacturing landscape shaping emerging healthcare markets.

World Health Expo (WHX) Dubai 2026, formerly known as Arab Health, has evolved from a conventional product showcase into one of the world’s largest dialogue platforms for healthcare implementation. Bringing together exhibitions, education, policy dialogue, investment, and procurement within a single setting, WHX convenes healthcare professionals, policymakers, industry leaders, and investors to accelerate decision‑making across the global health ecosystem. 

This rapid brief highlights how the breadth and depth of WHX’s agenda enable perspectives that transcend individual technologies or markets. In particular, two themes stood out. First, Women’s Health was positioned not as a niche domain but as a core systems issue, reframed through a life‑course perspective spanning childhood to older age. Sessions emphasized that integrating diagnostics, data, and care pathways across the life course can address long‑standing evidence gaps and unlock substantial economic and societal value. Second, WHX reflected its Middle Eastern context by advancing strategic discussions on Africa as a growth market, with Egypt emerging as a pragmatic entry point for manufacturing and regulatory alignment, supported by evolving continental frameworks such as the African Medicines Agency (AMA). 

The juxtaposition of these themes—life‑course‑oriented Women’s Health and Middle East–Africa (MEA) market strategies—was particularly instructive. Discussions following Women’s Health sessions, including contributions from African speakers, illustrated how demand‑side health needs and supply‑side manufacturing and regulatory capacity can be aligned to create scalable, sustainable business models. 

For Japanese stakeholders, WHX Dubai 2026 underscores the importance of moving beyond episodic participation toward strategic engagement. By combining integrated Women’s Health services, early regulatory and quality readiness, and MEA‑oriented market architecture, WHX offers a platform not only to observe emerging trends, but to actively shape implementation pathways for other domains in fast‑growing markets as well.